Skip to content
Verastem, Inc.
  • Our Science
    • Pipeline
      • RAS Pathway
      • Avutometinib (RAF/MEK Clamp)
      • Defactinib (FAK Inhibitor)
      • Avutometinib as a Backbone of Therapy
    • Clinical Trials
    • Resources
  • Our Medicines
  • Medical Professionals
    • Overview
    • HCP Resources
      • Request Medical Information
      • Medical Education Grants and Scholarships
      • Investigator Sponsored Trials
      • Expanded Access
  • Investors & Media
    • Overview
    • News & Media
      • Press Releases
      • Media Resources
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • IR Resources
  • Patients & Advocacy
  • Who We Are
    • Our Culture
    • Our Leadership
    • Join Us
  • Contact
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request
Home » Our Medicines

Our Medicines

Approved in the U.S.

For more information, please review:

(For U.S. audiences only)

Healthcare Providers

View full prescribing information

Patients

View patient information

Learn more about our Expanded Access policy.

To request medical information or to report an adverse event or product complaint, please call Verastem Medical Information Services as 1-833-633-8786 or email medinfo@verastem.com.

AVMAPKI and FAKZYNJA are trademarks of Verastem, Inc.

  • Terms of Use
  • Compliance & Ethics
  • Copyright Statement
  • Privacy Policy
  • Contact
  • Sitemap
  • Twitter
  • Linkedin
© 2025 Verastem, Inc. All Rights Reserved.